These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36646051)

  • 1. Evaluation of Microvascular Rarefaction in Vascular Cognitive Impairment and Heart Failure (CRUCIAL): Study Protocol for an Observational Study.
    van Dinther M; Bennett J; Thornton GD; Voorter PHM; Ezponda Casajús A; Hughes A; Captur G; Holtackers RJ; ; Staals J; Backes WH; Bastarika G; Jones EAV; González A; van Oostenbrugge RJ; Treibel TA
    Cerebrovasc Dis Extra; 2023; 13(1):18-32. PubMed ID: 36646051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging.
    Tarantini S; Tucsek Z; Valcarcel-Ares MN; Toth P; Gautam T; Giles CB; Ballabh P; Wei JY; Wren JD; Ashpole NM; Sonntag WE; Ungvari Z; Csiszar A
    Age (Dordr); 2016 Aug; 38(4):273-289. PubMed ID: 27613724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design.
    Ali D; Callan N; Ennis S; Powell R; McGuire S; McGregor G; Weickert MO; Miller MA; Cappuccio FP; Banerjee P
    BMJ Open; 2019 Nov; 9(11):e027984. PubMed ID: 31748285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of microvascular rarefaction in human brain disorders using physiological magnetic resonance imaging.
    van Dinther M; Voorter PH; Jansen JF; Jones EA; van Oostenbrugge RJ; Staals J; Backes WH
    J Cereb Blood Flow Metab; 2022 May; 42(5):718-737. PubMed ID: 35078344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols.
    Lu H; Kashani AH; Arfanakis K; Caprihan A; DeCarli C; Gold BT; Li Y; Maillard P; Satizabal CL; Stables L; Wang DJJ; Corriveau RA; Singh H; Smith EE; Fischl B; van der Kouwe A; Schwab K; Helmer KG; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):716-725. PubMed ID: 33480157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction.
    Zeng H; Chen JX
    Front Cardiovasc Med; 2019; 6():15. PubMed ID: 30873415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
    Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
    Dryer K; Gajjar M; Narang N; Lee M; Paul J; Shah AP; Nathan S; Butler J; Davidson CJ; Fearon WF; Shah SJ; Blair JEA
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1033-H1042. PubMed ID: 29424571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction.
    Srivaratharajah K; Coutinho T; deKemp R; Liu P; Haddad H; Stadnick E; Davies RA; Chih S; Dwivedi G; Guo A; Wells GA; Bernick J; Beanlands R; Mielniczuk LM
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
    Rossitto G; Mary S; McAllister C; Neves KB; Haddow L; Rocchiccioli JP; Lang NN; Murphy CL; Touyz RM; Petrie MC; Delles C
    J Am Coll Cardiol; 2020 Dec; 76(24):2817-2829. PubMed ID: 33303070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the intravascular and interstitial compartments of remodeled myocardium in heart failure patients with preserved and reduced ejection fraction: a CMR study.
    Masci PG; Pavon AG; Berchier G; Schwitter J
    BMC Med Imaging; 2019 Jan; 19(1):1. PubMed ID: 30611240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
    Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
    Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction.
    Tona F; Montisci R; Iop L; Civieri G
    Rev Cardiovasc Med; 2021 Mar; 22(1):97-104. PubMed ID: 33792251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.
    Gorelick PB; Scuteri A; Black SE; Decarli C; Greenberg SM; Iadecola C; Launer LJ; Laurent S; Lopez OL; Nyenhuis D; Petersen RC; Schneider JA; Tzourio C; Arnett DK; Bennett DA; Chui HC; Higashida RT; Lindquist R; Nilsson PM; Roman GC; Sellke FW; Seshadri S;
    Stroke; 2011 Sep; 42(9):2672-713. PubMed ID: 21778438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging retinal microvascular manifestations of carotid artery disease in older adults: from diagnosis of ocular complications to understanding microvascular contributions to cognitive impairment.
    István L; Czakó C; Élő Á; Mihály Z; Sótonyi P; Varga A; Ungvári Z; Csiszár A; Yabluchanskiy A; Conley S; Csipő T; Lipecz Á; Kovács I; Nagy ZZ
    Geroscience; 2021 Aug; 43(4):1703-1723. PubMed ID: 34100219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired skeletal muscle performance as a consequence of random functional capillary rarefaction can be restored with overload-dependent angiogenesis.
    Tickle PG; Hendrickse PW; Degens H; Egginton S
    J Physiol; 2020 Mar; 598(6):1187-1203. PubMed ID: 32012275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual functional capillary rarefaction in chronic heart failure.
    Wadowski PP; Hülsmann M; Schörgenhofer C; Lang IM; Wurm R; Gremmel T; Koppensteiner R; Steinlechner B; Schwameis M; Jilma B
    Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29178250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.